Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C

Biochemical and Biophysical Research Communications

Volumn 281, Issue 4, 2001, Pages 891-896

  Hattori, Yoshiyuki ^a   Kakishita, Hirobumi ^a   Akimoto, Kazumi ^a   Matsumura, Mihoko ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Glycated serum albumin; MAP kinase; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; GLYCOSYLATED ALBUMIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C DELTA INHIBITOR; PROTEIN KINASE C INHIBITOR; ROTTLERIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITOR INTERACTION; ENZYME MECHANISM; ENZYME REGULATION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

EID: 0034804569     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4436     Document Type: Article

References (26)

1. Advanced glycation end-products and atherosclerosis
2. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
3. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo
4. The glycosylation of hemoglobin: Relevance to diabetes mellitus
5. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin
6. Glycated albumin promotes a generalized vasculopathy in the db/db mouse
7. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin
8. Role of Amadori-modifed nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy
9. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice
10. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus
11. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy
12. Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries
13. The mitogen-activated protein kinase signal transduction pathway
14. The MAPK signaling cascade
15. Signal transduction in arteriosclerosis: Mechanical stress-activated MAP kinases in vascular smooth muscle cells
16. Growth factors and mitogen-activated protein kinases
17. The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II
18. Biochemical analysis of transcriptional activation by Jun: Differential activity of c- and v-Jun
19. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
20. Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes
21. Dissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Relevant roles of protein kinase C
22. Protein kinase cdelta and alpha are involved in the development of vasospasm after subarachnoid hemorrhage
23. Contractile potentiation by endothelin-1 involves protein kinase C-delta activity in the porcine coronary artery
24. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression
25. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects
26. Serum albumin